What researchers published on Mesothelioma
602 papers, newest first.
Showing 20 of 602
Not labelled yetEvolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016-2022.Pulmonology
Not labelled yetOutcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.JTO clinical and research reports
Not labelled yetMultiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research
Not labelled yet[Current State of the Asbestos Outpatient Clinic and an Evaluation of Asbestos Bodies].Kyobu geka. The Japanese journal of thoracic surgery
Case report[Surgical Case of Primary Malignant Pericardial Mesothelioma].Kyobu geka. The Japanese journal of thoracic surgery
Not labelled yetUSP14 promotes malignant pleural mesothelioma progression and suppresses autophagy by stabilizing the YAP1-TEAD4 axis.Molecular biology reports
ReviewCross-lineage mesenchymal transition in mesothelioma.Cancer metastasis reviews
Not labelled yetPrognostic factors after multimodality treatment for pleural mesothelioma.Interdisciplinary cardiovascular and thoracic surgery
Not labelled yetPrognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.Frontiers in oncology
Not labelled yetMultimodality imaging in the diagnosis and staging of malignant pleural mesothelioma.BMJ case reports
Not labelled yetAnti-Ma1/Ma2 paraneoplastic neurological syndrome associated with malignant mesothelioma: a case study.BMJ neurology open
Not labelled yetMachine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
Not labelled yetPost-Recurrence Treatment Patterns and Outcomes After Curative-Intent Multimodality Strategy in Patients with Pleural Mesothelioma: A Retrospective Cohort Study.Journal of clinical medicine
Not labelled yetPrognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes.Journal of clinical medicine
Not labelled yetTreatment-specific Association of H&E-based Stromal Tumor-infiltrating Lymphocytes With Survival in Pleural Mesothelioma Treated With Ipilimumab/Nivolumab or Chemotherapy.Anticancer research
ReviewMTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches.Cancers
Not labelled yetCorrection: Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.PloS one
Not labelled yetIntegrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma.Cancer reports (Hoboken, N.J.)
Not labelled yetHMGB1 directly activates BAP1 transcription to sustain tumor growth in mesothelioma.Cell death and differentiation
ReviewReprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity.Frontiers in immunology